World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
67
Citations
29213
World Ranking
8048
National Ranking
3649

Overview

James B. McMahon is affiliated with the National Institutes of Health in the United States. Their research spans multiple fields, primarily focusing on Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these areas, key subfields of study include Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, and Hepatology.

The main topics of McMahon's work cover a range of biomedical subjects related to immune system functions and disease mechanisms. These topics include:

  • Immune cells in cancer
  • IL-33, ST2, and ILC Pathways
  • Extracellular vesicles in disease
  • Protein Degradation and Inhibitors
  • Genomics and Chromatin Dynamics
  • FOXO transcription factor regulation
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

McMahon has contributed to research published in various scientific venues. Frequent publication outlets include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Radiotherapy and Oncology
  • Science Immunology
  • Nature Communications

Notable recent publications by McMahon consist of:

  • Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation, 2023, Science Immunology
  • KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma, 2024, Nature Communications
  • Identification of a Broadly Fibrogenic Macrophage Subset Induced by Type 3 Inflammation in Human and Murine Liver and Lung Fibrosis, 2022, bioRxiv (Cold Spring Harbor Laboratory)
  • PD-0938 impact of an atlas on radiographer inter-observer contour variation in prostate radiotherapy, 2021, Radiotherapy and Oncology
  • PO-1952 Quantification of MRI distortion in patients with metallic hip prosthesis: a feasibility study, 2021, Radiotherapy and Oncology

Frequent collaborators in McMahon's work include:

  • Thomas Fabre
  • Alex Barron
  • Thomas A. Wynn
  • Stephen M. Christensen
  • Shoh Asano

Best Publications

  • New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

    Philip Skehan;Ritsa Storeng;Dominic Scudiero;Anne Monks

  • Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.

    M R Boyd;K R Gustafson;J B McMahon;R H Shoemaker

  • The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.

    Yoel Kashman;Kirk R. Gustafson;Richard W. Fuller;John H. Cardellina

  • Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.

    Toshiyuki Mori;Barry R. O'Keefe;Raymond C. Sowder;Scott Bringans

  • Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivity

    David A. Cooney;Maha Dalal;Hiroaki Mitsuya;James B. McMahon

  • Circulins A and B. Novel human immunodeficiency virus (HIV)-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia.

    Kirk R. Gustafson;Raymond C. Sowder;Louis E. Henderson;Ian C. Parsons

  • Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

    Barry R. O'Keefe;Barbara Giomarelli;Dale L. Barnard;Shilpa R. Shenoy

  • Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions.

    Eddie W Adams;Daniel M Ratner;Heidi R Bokesch;James B McMahon

  • Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

    Barry R. O'Keefe;Fakhrieh Vojdani;Viviana Buffa;Robin J. Shattock

  • The guttiferones, HIV-inhibitory benzophenones from Symphonia globulifera, Garcinia livingstonei, Garcinia ovalifolia and Clusia rosea

    Kirk R. Gustafson;John W. Blunt;Murray H.G. Munro;Richard W. Fuller

  • Anti-HIV michellamines from Ancistrocladus korupensis.

    Michael R. Boyd;Yali F. Hallock;John H. CardellinaII;Kirk P. Manfredi

  • A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1

    Kirk R. Gustafson;John H. Cardellina;James B. McMahon;Robert J. Gulakowski

  • Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones

    Scott R. Budihas;Inna Gorshkova;Sergei Gaidamakov;Antony Wamiru

  • Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2.

    Kirk P. Manfredi;John W. Blunt;John H. Cardellina;James B. McMahon

  • Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice.

    Theodore L. McLemore;Mark C. Liu;Penny C. Blacker;Marybelle Gregg

  • Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening

    Patrick J. Grohar;Girma M. Woldemichael;Laurie B. Griffin;Arnulfo Mendoza

  • Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner.

    Anders J. Bolmstedt;Barry R. O'Keefe;Shilpa R. Shenoy;James B. McMahon

  • A semiautomated multiparameter approach for anti-HIV drug screening.

    Robert J. Gulakowski;James B. McMahon;Patricia G. Staley;Robert A. Moran

  • Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1

    Sang-Moon Yun;Tinoush Moulaei;Dan Lim;Jeong K. Bang

  • Domain-Swapped Structure of the Potent Antiviral Protein Griffithsin and Its Mode of Carbohydrate Binding

    Natasza E. Ziółkowska;Barry R. O'Keefe;Toshiyuki Mori;Charles Zhu

Frequent Co-Authors

Kirk R. Gustafson
Kirk R. Gustafson National Institutes of Health
Barry R. O'Keefe
Barry R. O'Keefe National Institutes of Health
Michael R. Boyd
Michael R. Boyd National Cancer Institute
John A. Beutler
John A. Beutler National Institutes of Health
John H. Cardellina
John H. Cardellina Montana State University
Michael R. Boyd
Michael R. Boyd University of South Alabama
Nancy H. Colburn
Nancy H. Colburn National Institutes of Health
Robert H. Shoemaker
Robert H. Shoemaker National Institutes of Health
Yoel Kashman
Yoel Kashman Tel Aviv University
Robert W. Buckheit
Robert W. Buckheit ImQuest BioSciences (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing James B. McMahon

Trending Scientists